| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | CXW | Common Stock | Sale | -$80K | -7.5K | -2.31% | $10.66 | 317K | Feb 15, 2023 | Direct | F1, F2 |
| transaction | CXW | Common Stock | Award | $0 | +50.3K | +15.87% | $0.00 | 367K | Feb 16, 2023 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | This transaction was effective pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 19, 2022. The Rule 10b5-1 trading plan, which was structured to include several sale periods, was established as part of the Reporting Person's long-term strategy for asset diversification and financial, retirement, estate and tax planning activities over a period of time. |
| F2 | The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $10.51 to $10.78, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. |
| F3 | Represents restricted stock units (RSU's) granted to the Reporting Person on February 16, 2023 (the Grant Date). Each RSU represents a contingent right to receive one share of the Issuer's common stock. The RSU's vest annually in one-third increments on the later of the (i) first, second, and third anniversary of the award or (ii) the date on which the Company's annual report on Form 10-K is filed in each respective year. |